DALLAS, Feb. 23, 2010 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring biotech company Cord Blood America Inc. (OTCBB:CBAI). The report includes financial, comparative and investment analysis, and industry information you need to know to make an educated investment decision.
The full report is available at: http://www.beaconequity.com/i/CBAI
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/BeaconEquity
Cord Blood America Inc. (CBAI) markets and provides patented services through its subsidiaries CorCell Companies Inc. and Cord Partners Inc. to preserve umbilical cord blood for later use by the donator's family. Cryogenically preserved umbilical cord stem blood is shown to be effective in the treatment of approximately 75 diseases, including immune deficiencies, blood diseases and disorders, leukemia and acute anemia.
In the report, the analyst notes:
"The Cord division provides a collection kit--a medical supplies package used to collect the newborn's umbilical cord blood as well as packaging supplies to be used for submission of the cord blood to the Company's lab where it will be sampled and tested.
"In its latest 10-Q filing with the SEC, the Company states that it continues to improve its relationship with more health insurance providers, obstetrics professionals, other healthcare professionals and hospitals. The Company states that it also intends to leverage its business model by mergers and acquisitions of other stem cell preservation companies.
"The Company seeks to acquire or develop organically the ability to provide products and services relating to the collection, processing and preserving of peripheral blood and adipose tissue stem cells. The idea supporting the BodyCells division focuses upon the anticipated demand for private preservation of stem cells."
To read the entire report visit: http://www.beaconequity.com/i/CBAI
See what investors are saying about these stocks at penny stock forum.
BeaconEquity.com is one of the industry's largest small-cap report providers striving to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit http://www.BeaconEquity.com
Beacon Equity Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Beacon Equity nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.